肺動脈弁置換術の市場(弁の種類:機械弁、生体弁、用途:肺動脈弁狭窄症、肺動脈閉鎖症、その他) - 世界の産業分析、サイズ、シェア、成長、トレンド、および予測、2023-2031年Pulmonary Valve Replacement Market (Valve Type: Mechanical Valve and Biological Valve; Application: Pulmonary Valve Stenosis, Pulmonary Atresia, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 肺動脈弁置換術の市場 - レポートの範囲 TMRの調査レポート「肺動脈弁置換の世界市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と... もっと見る
サマリー肺動脈弁置換術の市場 - レポートの範囲TMRの調査レポート「肺動脈弁置換の世界市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの期間における世界の肺動脈弁置換市場の収益を提供します。また、2023年から2031年までの肺動脈弁置換の世界市場の複合年間成長率(CAGR %)を掲載しています。 本レポートは、広範な調査を経て作成されました。一次調査では、主要なオピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査作業の大部分を行いました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、肺動脈弁置換市場を把握しました。 二次調査には、インターネットソース、政府機関、ウェブサイト、業界団体の統計データも含まれます。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、肺動脈弁置換の世界市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは、肺動脈弁置換の世界市場における競争力学の変化に光を当てています。これらは、既存の市場関係者だけでなく、世界の肺動脈弁置換市場への参入を検討している企業にとっても、貴重なツールとなります。 本レポートは、世界の肺動脈弁置換市場の競争環境について掘り下げています。世界の肺動脈弁置換市場で活動する主要企業が特定され、これらの各企業は様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の肺動脈弁置換市場のプレーヤーの属性です。 肺動脈弁置換の世界市場レポートで回答された主要な質問 - 予測期間中の全地域における肺動脈弁置換の売上高/収益はどの程度か? - 世界の肺動脈弁置換市場における機会は何か? - 市場における主な推進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大するのはどの地域市場か? - 2031年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントはどこか? - 世界市場で事業展開している各社の市場ポジションは? 肺動脈弁置換市場 - 研究目的と研究アプローチ 肺動脈弁置換の世界市場に関する包括的なレポートは、概要から始まり、研究の範囲と目的について説明しています。本調査の目的、市場で活動する主要ベンダーや流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 読みやすさを考慮し、本レポートは章立てでまとめられ、各セクションはより小さなものに分割されています。本レポートは、グラフと表が適切に配置された包括的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えかけています。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することも可能です。 本レポートでは、肺動脈弁置換術の世界市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントごとの市場シェアを掲載しています。このような貴重な洞察により、市場関係者は、世界の肺動脈弁置換市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Pulmonary Valve Replacement Market 4. Market Overview 4.1. Introduction 4.1.1. Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Pulmonary Valve Replacement Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Bn) 5. Key Insights 5.1. Key Industry Events 5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact) 5.3. Pricing Analysis of Different Mechanical Valves 5.4. Pulmonary Diseases Prevalence Overview 6. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Valve Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Valve Type, 2017-2031 6.3.1. Mechanical Valve 6.3.2. Biological Valve 6.3.2.1. Donor Valve 6.3.2.2. Tissue Valve 6.4. Market Attractiveness Analysis, by Valve Type 7. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Application 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Application, 2017-2031 7.3.1. Pulmonary Valve Stenosis 7.3.2. Pulmonary Atresia 7.3.3. Others 7.4. Market Attractiveness Analysis, by Application 8. Global Pulmonary Valve Replacement Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2017-2031 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.3.3. Others 8.4. Market Attractiveness Analysis, by End-user 9. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Region 10. North America Pulmonary Valve Replacement Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Valve Type, 2017-2031 10.2.1. Mechanical Valve 10.2.2. Biological Valve 10.2.2.1. Donor Valve 10.2.2.2. Tissue Valve 10.3. Market Value Forecast, by Application, 2017-2031 10.3.1. Pulmonary Valve Stenosis 10.3.2. Pulmonary Atresia 10.3.3. Others 10.4. Market Value Forecast, by End-user, 2017-2031 10.4.1. Hospitals 10.4.2. Ambulatory Surgical Centers 10.4.3. Others 10.5. Market Value Forecast, by Country, 2017-2031 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Valve Type 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country 11. Europe Pulmonary Valve Replacement Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Valve Type, 2017-2031 11.2.1. Mechanical Valve 11.2.2. Biological Valve 11.2.2.1. Donor Valve 11.2.2.2. Tissue Valve 11.3. Market Value Forecast, by Application, 2017-2031 11.3.1. Pulmonary Valve Stenosis 11.3.2. Pulmonary Atresia 11.3.3. Others 11.4. Market Value Forecast, by End-user, 2017-2031 11.4.1. Hospitals 11.4.2. Ambulatory Surgical Centers 11.4.3. Others 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031 11.5.1. Germany 11.5.2. U.K. 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Valve Type 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Pulmonary Valve Replacement Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Valve Type, 2017-2031 12.2.1. Mechanical Valve 12.2.2. Biological Valve 12.2.2.1. Donor Valve 12.2.2.2. Tissue Valve 12.3. Market Value Forecast, by Application, 2017-2031 12.3.1. Pulmonary Valve Stenosis 12.3.2. Pulmonary Atresia 12.3.3. Others 12.4. Market Value Forecast, by End-user, 2017-2031 12.4.1. Hospitals 12.4.2. Ambulatory Surgical Centers 12.4.3. Others 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031 12.5.1. China 12.5.2. Japan 12.5.3. India 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Valve Type 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Pulmonary Valve Replacement Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Valve Type, 2017-2031 13.2.1. Mechanical Valve 13.2.2. Biological Valve 13.2.2.1. Donor Valve 13.2.2.2. Tissue Valve 13.3. Market Value Forecast, by Application, 2017-2031 13.3.1. Pulmonary Valve Stenosis 13.3.2. Pulmonary Atresia 13.3.3. Others 13.4. Market Value Forecast, by End-user, 2017-2031 13.4.1. Hospitals 13.4.2. Ambulatory Surgical Centers 13.4.3. Others 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Valve Type 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Pulmonary Valve Replacement Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Valve Type, 2017-2031 14.2.1. Mechanical Valve 14.2.2. Biological Valve 14.2.2.1. Donor Valve 14.2.2.2. Tissue Valve 14.3. Market Value Forecast, by Application, 2017-2031 14.3.1. Pulmonary Valve Stenosis 14.3.2. Pulmonary Atresia 14.3.3. Others 14.4. Market Value Forecast, by End-user, 2017-2031 14.4.1. Hospitals 14.4.2. Ambulatory Surgical Centers 14.4.3. Others 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031 14.5.1. GCC Countries 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Valve Type 14.6.2. By Application 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competition Matrix (by tier and size of companies) 15.2. Market Share Analysis, by Company, 2022 15.3. Company Profiles 15.3.1. Boston Scientific 15.3.1.1. Company Overview 15.3.1.2. Valve Type Portfolio 15.3.1.3. SWOT Analysis 15.3.1.4. Strategic Overview 15.3.2. Edwards Lifesciences 15.3.2.1. Company Overview 15.3.2.2. Valve Type Portfolio 15.3.2.3. SWOT Analysis 15.3.2.4. Strategic Overview 15.3.3. Medtronic 15.3.3.1. Company Overview 15.3.3.2. Valve Type Portfolio 15.3.3.3. SWOT Analysis 15.3.3.4. Strategic Overview 15.3.4. St. Jude Medical 15.3.4.1. Company Overview 15.3.4.2. Valve Type Portfolio 15.3.4.3. SWOT Analysis 15.3.4.4. Strategic Overview 15.3.5. Abbott 15.3.5.1. Company Overview 15.3.5.2. Valve Type Portfolio 15.3.5.3. SWOT Analysis 15.3.5.4. Strategic Overview 15.3.6. Cryolife 15.3.6.1. Company Overview 15.3.6.2. Valve Type Portfolio 15.3.6.3. SWOT Analysis 15.3.6.4. Strategic Overview 15.3.7. LivaNova, Inc. 15.3.7.1. Company Overview 15.3.7.2. Valve Type Portfolio 15.3.7.3. SWOT Analysis 15.3.7.4. Strategic Overview 15.3.8. 4C Medical Technologies, Inc. 15.3.8.1. Company Overview 15.3.8.2. Valve Type Portfolio 15.3.8.3. SWOT Analysis 15.3.8.4. Strategic Overview 図表リストList of TablesTable 01: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 02: Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by 2017‒2031, by Application Table 03: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 04: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Region, 2017–2031 Table 05: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country, 2017–2031 Table 06: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 07: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 08: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 09: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031 Table 10: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 11: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 12: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 13: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031 Table 14: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 15: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 16: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 17: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031 Table 18: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 19: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 20: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 21: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031 Table 22: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 23: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 24: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
SummaryPulmonary Valve Replacement Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Pulmonary Valve Replacement Market 4. Market Overview 4.1. Introduction 4.1.1. Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Pulmonary Valve Replacement Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Bn) 5. Key Insights 5.1. Key Industry Events 5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact) 5.3. Pricing Analysis of Different Mechanical Valves 5.4. Pulmonary Diseases Prevalence Overview 6. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Valve Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Valve Type, 2017-2031 6.3.1. Mechanical Valve 6.3.2. Biological Valve 6.3.2.1. Donor Valve 6.3.2.2. Tissue Valve 6.4. Market Attractiveness Analysis, by Valve Type 7. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Application 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Application, 2017-2031 7.3.1. Pulmonary Valve Stenosis 7.3.2. Pulmonary Atresia 7.3.3. Others 7.4. Market Attractiveness Analysis, by Application 8. Global Pulmonary Valve Replacement Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2017-2031 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.3.3. Others 8.4. Market Attractiveness Analysis, by End-user 9. Global Pulmonary Valve Replacement Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Region 10. North America Pulmonary Valve Replacement Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Valve Type, 2017-2031 10.2.1. Mechanical Valve 10.2.2. Biological Valve 10.2.2.1. Donor Valve 10.2.2.2. Tissue Valve 10.3. Market Value Forecast, by Application, 2017-2031 10.3.1. Pulmonary Valve Stenosis 10.3.2. Pulmonary Atresia 10.3.3. Others 10.4. Market Value Forecast, by End-user, 2017-2031 10.4.1. Hospitals 10.4.2. Ambulatory Surgical Centers 10.4.3. Others 10.5. Market Value Forecast, by Country, 2017-2031 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Valve Type 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country 11. Europe Pulmonary Valve Replacement Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Valve Type, 2017-2031 11.2.1. Mechanical Valve 11.2.2. Biological Valve 11.2.2.1. Donor Valve 11.2.2.2. Tissue Valve 11.3. Market Value Forecast, by Application, 2017-2031 11.3.1. Pulmonary Valve Stenosis 11.3.2. Pulmonary Atresia 11.3.3. Others 11.4. Market Value Forecast, by End-user, 2017-2031 11.4.1. Hospitals 11.4.2. Ambulatory Surgical Centers 11.4.3. Others 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031 11.5.1. Germany 11.5.2. U.K. 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Valve Type 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Pulmonary Valve Replacement Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Valve Type, 2017-2031 12.2.1. Mechanical Valve 12.2.2. Biological Valve 12.2.2.1. Donor Valve 12.2.2.2. Tissue Valve 12.3. Market Value Forecast, by Application, 2017-2031 12.3.1. Pulmonary Valve Stenosis 12.3.2. Pulmonary Atresia 12.3.3. Others 12.4. Market Value Forecast, by End-user, 2017-2031 12.4.1. Hospitals 12.4.2. Ambulatory Surgical Centers 12.4.3. Others 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031 12.5.1. China 12.5.2. Japan 12.5.3. India 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Valve Type 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Pulmonary Valve Replacement Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Valve Type, 2017-2031 13.2.1. Mechanical Valve 13.2.2. Biological Valve 13.2.2.1. Donor Valve 13.2.2.2. Tissue Valve 13.3. Market Value Forecast, by Application, 2017-2031 13.3.1. Pulmonary Valve Stenosis 13.3.2. Pulmonary Atresia 13.3.3. Others 13.4. Market Value Forecast, by End-user, 2017-2031 13.4.1. Hospitals 13.4.2. Ambulatory Surgical Centers 13.4.3. Others 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Valve Type 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Pulmonary Valve Replacement Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Valve Type, 2017-2031 14.2.1. Mechanical Valve 14.2.2. Biological Valve 14.2.2.1. Donor Valve 14.2.2.2. Tissue Valve 14.3. Market Value Forecast, by Application, 2017-2031 14.3.1. Pulmonary Valve Stenosis 14.3.2. Pulmonary Atresia 14.3.3. Others 14.4. Market Value Forecast, by End-user, 2017-2031 14.4.1. Hospitals 14.4.2. Ambulatory Surgical Centers 14.4.3. Others 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031 14.5.1. GCC Countries 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Valve Type 14.6.2. By Application 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competition Matrix (by tier and size of companies) 15.2. Market Share Analysis, by Company, 2022 15.3. Company Profiles 15.3.1. Boston Scientific 15.3.1.1. Company Overview 15.3.1.2. Valve Type Portfolio 15.3.1.3. SWOT Analysis 15.3.1.4. Strategic Overview 15.3.2. Edwards Lifesciences 15.3.2.1. Company Overview 15.3.2.2. Valve Type Portfolio 15.3.2.3. SWOT Analysis 15.3.2.4. Strategic Overview 15.3.3. Medtronic 15.3.3.1. Company Overview 15.3.3.2. Valve Type Portfolio 15.3.3.3. SWOT Analysis 15.3.3.4. Strategic Overview 15.3.4. St. Jude Medical 15.3.4.1. Company Overview 15.3.4.2. Valve Type Portfolio 15.3.4.3. SWOT Analysis 15.3.4.4. Strategic Overview 15.3.5. Abbott 15.3.5.1. Company Overview 15.3.5.2. Valve Type Portfolio 15.3.5.3. SWOT Analysis 15.3.5.4. Strategic Overview 15.3.6. Cryolife 15.3.6.1. Company Overview 15.3.6.2. Valve Type Portfolio 15.3.6.3. SWOT Analysis 15.3.6.4. Strategic Overview 15.3.7. LivaNova, Inc. 15.3.7.1. Company Overview 15.3.7.2. Valve Type Portfolio 15.3.7.3. SWOT Analysis 15.3.7.4. Strategic Overview 15.3.8. 4C Medical Technologies, Inc. 15.3.8.1. Company Overview 15.3.8.2. Valve Type Portfolio 15.3.8.3. SWOT Analysis 15.3.8.4. Strategic Overview List of Tables/GraphsList of TablesTable 01: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 02: Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by 2017‒2031, by Application Table 03: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 04: Global Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Region, 2017–2031 Table 05: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country, 2017–2031 Table 06: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 07: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 08: North America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 09: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031 Table 10: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 11: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 12: Europe Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 13: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2031 Table 14: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 15: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 16: Asia Pacific Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 17: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031 Table 18: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 19: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 20: Latin America Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031 Table 21: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031 Table 22: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Valve Type, 2017‒2031 Table 23: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by Application, 2017‒2031 Table 24: Middle East & Africa Pulmonary Valve Replacement Market Value (US$ Bn) Forecast, by End-user, 2017–2031
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポートTransparency Market Research社の医療分野での最新刊レポート
本レポートと同じKEY WORD(analysis size)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |